AJANTA PHARMA
Back to Balance Sheet
|
AJANTA PHARMA Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹2,320 Cr | ₹1,834 Cr | ₹1,827 Cr | ₹1,686 Cr | ₹1,617 Cr |
What is the latest Net Current Assets ratio of AJANTA PHARMA ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹2,320 Cr |
| Mar2025 | ₹1,834 Cr |
| Mar2024 | ₹1,827 Cr |
| Mar2023 | ₹1,686 Cr |
| Mar2022 | ₹1,617 Cr |
How is Net Current Assets of AJANTA PHARMA Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,320 Cr | 26.51 | |
| Mar2025 | ₹1,834 Cr | 0.37 | |
| Mar2024 | ₹1,827 Cr | 8.36 | |
| Mar2023 | ₹1,686 Cr | 4.26 | |
| Mar2022 | ₹1,617 Cr | - | |
Compare Net Current Assets of peers of AJANTA PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AJANTA PHARMA | ₹41,435.6 Cr | -0.9% | 11.4% | 31% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,593.0 Cr | 2% | 6.7% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,737.0 Cr | 3.5% | 2.2% | 0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹164,290.0 Cr | 4.6% | 9.9% | 41.5% | Stock Analytics | |
| CIPLA | ₹117,327.0 Cr | -0.3% | 3.7% | -2.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,994.0 Cr | 1.1% | 5.9% | 6.6% | Stock Analytics | |
AJANTA PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AJANTA PHARMA | -0.9% |
11.4% |
31% |
| SENSEX | 2.2% |
5.1% |
-7% |
You may also like the below Video Courses